Article Details
Retrieved on: 2024-03-23 11:04:02
Tags for this article:
Click the tags to see associated articles and topics
Summary
The FDA authorized a new antibody drug, Pemgarda by Invivyd, for immunocompromised individuals, offering protection against COVID-19 variants like Omicron, following the ineffectiveness of AstraZeneca's Evusheld.
Article found on: www.statnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here